Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec(®), Gleevec™)

por Henkes, Martin, van der Kuip, Heiko, Aulitzky, Walter E
Publicado 2008

c-erbB2 and topoisomerase IIα protein expression independently predict poor survival in primary human breast cancer: a retrospective study

por Fritz, Peter, Cabrera, Cristina M, Dippon, Jürgen, Gerteis, Andreas, Simon, Wolfgang, Aulitzky, Walter E, van der Kuip, Heiko
Publicado 2005

Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells

por Kleih, Markus, Böpple, Kathrin, Dong, Meng, Gaißler, Andrea, Heine, Simon, Olayioye, Monilola A., Aulitzky, Walter E., Essmann, Frank
Publicado 2019

Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts

por Haubeiss, Silke, Schmid, Jens O, Mürdter, Thomas E, Sonnenberg, Maike, Friedel, Godehard, van der Kuip, Heiko, Aulitzky, Walter E
Publicado 2010

p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin

por Gutekunst, Matthias, Oren, Moshe, Weilbacher, Andrea, Dengler, Michael A., Markwardt, Christiane, Thomale, Jürgen, Aulitzky, Walter E., van der Kuip, Heiko
Publicado 2011

Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA

por Heine, Simon, Kleih, Markus, Giménez, Neus, Böpple, Kathrin, Ott, German, Colomer, Dolors, Aulitzky, Walter E., van der Kuip, Heiko, Silkenstedt, Elisabeth
Publicado 2018

Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast

por Sonnenberg, Maike, van der Kuip, Heiko, Haubeiß, Silke, Fritz, Peter, Schroth, Werner, Friedel, Godehard, Simon, Wolfgang, Mürdter, Thomas E, Aulitzky, Walter E
Publicado 2008

Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment

por van der Kuip, Heiko, Mürdter, Thomas E, Sonnenberg, Maike, McClellan, Monika, Gutzeit, Susanne, Gerteis, Andreas, Simon, Wolfgang, Fritz, Peter, Aulitzky, Walter E
Publicado 2006

Oncogenic Stress Induced by Acute Hyper-Activation of Bcr-Abl Leads to Cell Death upon Induction of Excessive Aerobic Glycolysis

por Dengler, Michael A., Staiger, Annette M., Gutekunst, Matthias, Hofmann, Ute, Doszczak, Malgorzata, Scheurich, Peter, Schwab, Matthias, Aulitzky, Walter E., van der Kuip, Heiko
Publicado 2011

The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA

por Weller, Sandra, Toennießen, Astrid, Schaefer, Benjamin, Beigl, Tobias, Muenchow, Alina, Böpple, Kathrin, Hofmann, Ute, Gillissen, Bernhard F., Aulitzky, Walter E., Kopp, Hans-Georg, Essmann, Frank
Publicado 2022

The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA

por Muenchow, Alina, Weller, Sandra, Hinterleitner, Clemens, Malenke, Elke, Bugl, Stefanie, Wirths, Stefan, Müller, Martin R., Schulze-Osthoff, Klaus, Aulitzky, Walter E., Kopp, Hans-Georg, Essmann, Frank
Publicado 2020

Perfusion Air Culture of Precision-Cut Tumor Slices: An Ex Vivo System to Evaluate Individual Drug Response under Controlled Culture Conditions

por Dong, Meng, Böpple, Kathrin, Thiel, Julia, Winkler, Bernd, Liang, Chunguang, Schueler, Julia, Davies, Emma J., Barry, Simon T., Metsalu, Tauno, Mürdter, Thomas E., Sauer, Georg, Ott, German, Schwab, Matthias, Aulitzky, Walter E.
Publicado 2023

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia

por Nelde, Annika, Maringer, Yacine, Bilich, Tatjana, Salih, Helmut R., Roerden, Malte, Heitmann, Jonas S., Marcu, Ana, Bauer, Jens, Neidert, Marian C., Denzlinger, Claudio, Illerhaus, Gerald, Aulitzky, Walter Erich, Rammensee, Hans-Georg, Walz, Juliane S.
Publicado 2021

Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy

por Silkenstedt, Elisabeth, Arenas, Fabian, Colom-Sanmartí, Berta, Xargay-Torrent, Sílvia, Higashi, Morihiro, Giró, Ariadna, Rodriguez, Vanina, Fuentes, Patricia, Aulitzky, Walter E., van der Kuip, Heiko, Beà, Sílvia, Toribio, Maria L., Campo, Elias, López-Guerra, Mònica, Colomer, Dolors
Publicado 2019

Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis

por Aylon, Yael, Furth, Noa, Mallel, Giuseppe, Friedlander, Gilgi, Nataraj, Nishanth Belugali, Dong, Meng, Hassin, Ori, Zoabi, Rawan, Cohen, Benjamin, Drendel, Vanessa, Salame, Tomer Meir, Mukherjee, Saptaparna, Harpaz, Nofar, Johnson, Randy, Aulitzky, Walter E., Yarden, Yosef, Shema, Efrat, Oren, Moshe
Publicado 2022

Author Correction: Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis

por Aylon, Yael, Furth, Noa, Mallel, Giuseppe, Friedlander, Gilgi, Nataraj, Nishanth Belugali, Dong, Meng, Hassin, Ori, Zoabi, Rawan, Cohen, Benjamin, Drendel, Vanessa, Salame, Tomer Meir, Mukherjee, Saptaparna, Harpaz, Nofar, Johnson, Randy, Aulitzky, Walter E., Yarden, Yosef, Shema, Efrat, Oren, Moshe
Publicado 2023

Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial

por Röllig, Christoph, Serve, Hubert, Noppeney, Richard, Hanoun, Maher, Krug, Utz, Baldus, Claudia D., Brandts, Christian H., Kunzmann, Volker, Einsele, Hermann, Krämer, Alwin, Müller-Tidow, Carsten, Schäfer-Eckart, Kerstin, Neubauer, Andreas, Burchert, Andreas, Giagounidis, Aristoteles, Krause, Stefan W., Mackensen, Andreas, Aulitzky, Walter, Herbst, Regina, Hänel, Mathias, Frickhofen, Norbert, Kullmer, Johannes, Kaiser, Ulrich, Kiani, Alexander, Link, Hartmut, Geer, Thomas, Reichle, Albrecht, Junghanß, Christian, Repp, Roland, Meinhardt, Achim, Dürk, Heinz, Klut, Ina-Maria, Bornhäuser, Martin, Schaich, Markus, Parmentier, Stefani, Görner, Martin, Thiede, Christian, von Bonin, Malte, Platzbecker, Uwe, Schetelig, Johannes, Kramer, Michael, Berdel, Wolfgang E., Ehninger, Gerhard
Publicado 2021

Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study

por Kayser, Sabine, Schlenk, Richard F., Lebon, Delphine, Carre, Martin, Götze, Katharina S., Stölzel, Friedrich, Berceanu, Ana, Schäfer-Eckart, Kerstin, Peterlin, Pierre, Hicheri, Yosr, Rahmé, Ramy, Raffoux, Emmanuel, Chermat, Fatiha, Krause, Stefan W., Aulitzky, Walter E., Rigaudeau, Sophie, Noppeney, Richard, Berthon, Celine, Görner, Martin, Jost, Edgar, Carassou, Philippe, Keller, Ulrich, Orvain, Corentin, Braun, Thorsten, Saillard, Colombe, Arar, Ali, Kunzmann, Volker, Wemeau, Mathieu, de Wit, Maike, Niemann, Dirk, Bonmati, Caroline, Schwänen, Carsten, Abraham, Julie, Aljijakli, Ahmad, Haiat, Stéphanie, Krämer, Alwin, Reichle, Albrecht, Gnadler, Martina, Willekens, Christophe, Spiekermann, Karsten, Hiddemann, Wolfgang, Müller-Tidow, Carsten, Thiede, Christian, Röllig, Christoph, Serve, Hubert, Bornhäuser, Martin, Baldus, Claudia D., Lengfelder, Eva, Fenaux, Pierre, Platzbecker, Uwe, Adès, Lionel
Publicado 2021